Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $3.18 Million - $4.07 Million
15,539 New
15,539 $3.18 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $1.4 Million - $1.82 Million
-6,541 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $965,491 - $1.11 Million
3,716 Added 131.54%
6,541 $1.73 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $335,697 - $388,363
-1,236 Reduced 30.44%
2,825 $888,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $1.12 Million - $1.25 Million
4,061 New
4,061 $1.14 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $2.13 Million - $2.57 Million
-12,758 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $1.45 Million - $2.33 Million
12,758 New
12,758 $2.12 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $137,180 - $256,793
-1,315 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $214,976 - $228,297
1,315 New
1,315 $222,000
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $818,661 - $912,584
-5,124 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $169,388 - $203,157
-1,175 Reduced 18.65%
5,124 $886,000
Q1 2019

May 13, 2019

SELL
$123.7 - $156.3 $849,695 - $1.07 Million
-6,869 Reduced 52.16%
6,299 $964,000
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $1.59 Million - $2.29 Million
13,168 New
13,168 $1.66 Million
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $661,122 - $742,348
-3,943 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $1.71 Million - $2.02 Million
-10,655 Reduced 72.99%
3,943 $708,000
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $2.36 Million - $2.6 Million
14,598 New
14,598 $2.36 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.